Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
Ankylosing spondylitis (AS) is one of the major inflammatory diseases that affect the vertebral column and joints. The first-line drugs for the treatment of this disease are now nonsteroidal anti-inflammatory drugs (NSAIDs) that not only reduce painful sensations and rigidity, but also retard the ra...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/437 |